Cargando…
Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis
The production of ergosterol lipid involves the activity of different enzymes and is a crucial event for the Leishmania membrane homeostasis. Such enzymes can be blocked by azoles and allylamines drugs, such as the antifungal butenafine chloride. This drug was active on parasites that cause cutaneou...
Autores principales: | Bezerra-Souza, Adriana, Jesus, Jéssica A., Laurenti, Márcia D., Lalatsa, Aikaterini, Serrano, Dolores R., Passero, Luiz Felipe D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046526/ https://www.ncbi.nlm.nih.gov/pubmed/33880383 http://dx.doi.org/10.1155/2021/8828750 |
Ejemplares similares
-
Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis
por: Bezerra-Souza, Adriana, et al.
Publicado: (2019) -
Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis
por: de Lima, Sarah Kymberly Santos, et al.
Publicado: (2023) -
Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
por: Jesus, Jéssica Adriana, et al.
Publicado: (2020) -
Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis
por: de Jesus, Jéssica Adriana, et al.
Publicado: (2021) -
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
por: Jesus, Jéssica A., et al.
Publicado: (2016)